480 related articles for article (PubMed ID: 37753266)
1. Non-Coding RNA in Microglia Activation and Neuroinflammation in Alzheimer's Disease.
He C; Li Z; Yang M; Yu W; Luo R; Zhou J; He J; Chen Q; Song Z; Cheng S
J Inflamm Res; 2023; 16():4165-4211. PubMed ID: 37753266
[TBL] [Abstract][Full Text] [Related]
2. Microglia Polarization in Alzheimer's Disease: Mechanisms and a Potential Therapeutic Target.
Wang Q; Yao H; Liu W; Ya B; Cheng H; Xing Z; Wu Y
Front Aging Neurosci; 2021; 13():772717. PubMed ID: 34819850
[TBL] [Abstract][Full Text] [Related]
3. Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer's Disease.
Shen Z; Bao X; Wang R
Front Aging Neurosci; 2018; 10():314. PubMed ID: 30349474
[TBL] [Abstract][Full Text] [Related]
4. Microglial polarization: novel therapeutic mechanism against Alzheimer's disease.
Yao K; Zu HB
Inflammopharmacology; 2020 Feb; 28(1):95-110. PubMed ID: 31264132
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.
Wang M; Tang G; Zhou C; Guo H; Hu Z; Hu Q; Li G
Chem Biol Interact; 2023 Apr; 375():110387. PubMed ID: 36758888
[TBL] [Abstract][Full Text] [Related]
6. Baicalein promotes the microglia M2 polarization and suppresses apoptosis by targeting HMOX1/PDE4D to alleviate Alzheimer's disease.
Gong Q; Wang Y; Wang X; Pan H; Yan C
Immunobiology; 2023 Nov; 228(6):152761. PubMed ID: 38006681
[TBL] [Abstract][Full Text] [Related]
7. Neuroinflammation of Microglial Regulation in Alzheimer's Disease: Therapeutic Approaches.
Chen H; Zeng Y; Wang D; Li Y; Xing J; Zeng Y; Liu Z; Zhou X; Fan H
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611758
[TBL] [Abstract][Full Text] [Related]
8. Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer's Disease.
Yang Y; Zhang Z
Front Aging Neurosci; 2020; 12():110. PubMed ID: 32477095
[TBL] [Abstract][Full Text] [Related]
9. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
10. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
11. Roles of Non-Coding RNA in Alzheimer's Disease Pathophysiology.
Olufunmilayo EO; Holsinger RMD
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569871
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
[TBL] [Abstract][Full Text] [Related]
13. Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer's Disease.
Xu YJ; Au NPB; Ma CHE
Front Aging Neurosci; 2022; 14():896852. PubMed ID: 35693341
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3: a key player in microglia-mediated neuroinflammation and Alzheimer's disease.
Tan Y; Zheng Y; Xu D; Sun Z; Yang H; Yin Q
Cell Biosci; 2021 Apr; 11(1):78. PubMed ID: 33906678
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.
Zhang Y; Zhao Y; Zhang J; Yang G
Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation in Alzheimer's disease: microglial signature and their relevance to disease.
Sobue A; Komine O; Yamanaka K
Inflamm Regen; 2023 May; 43(1):26. PubMed ID: 37165437
[TBL] [Abstract][Full Text] [Related]
17. Microglial activation occurs late during preclinical Alzheimer's disease.
Streit WJ; Braak H; Del Tredici K; Leyh J; Lier J; Khoshbouei H; Eisenlöffel C; Müller W; Bechmann I
Glia; 2018 Dec; 66(12):2550-2562. PubMed ID: 30417428
[TBL] [Abstract][Full Text] [Related]
18. M2 Macrophage Transplantation Ameliorates Cognitive Dysfunction in Amyloid-β-Treated Rats Through Regulation of Microglial Polarization.
Zhu D; Yang N; Liu YY; Zheng J; Ji C; Zuo PP
J Alzheimers Dis; 2016 Mar; 52(2):483-95. PubMed ID: 27003214
[TBL] [Abstract][Full Text] [Related]
19. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
20. TMEM16F may be a new therapeutic target for Alzheimer's disease.
Cui ZQ; Hu XY; Yang T; Guan JW; Gu Y; Li HY; Zhang HY; Xiao QH; Sun XH
Neural Regen Res; 2023 Mar; 18(3):643-651. PubMed ID: 36018189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
